A Post Marketing Surveillance Study of Cetuximab in Patients With Squamous Cell Carcinoma of Head and Neck (SCCHN)

NCT01080066 · clinicaltrials.gov ↗

COMPLETED

Status

215

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

OTHER: No Intervention

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]